top of page
Search


NEW STUDY: vEDS patients are living longer, but unclear what role celiprolol plays
In April 2019, an observational study of vascular EDS was published in the Journal of American College of Cardiology (link). The good news i

FIGHT vEDS Team
May 15, 20193 min read


Longer Life with vEDS: A Lesson from Marfan Syndrome
Recent vascular EDS literature estimated the average life expectancy at 51 years(1). While innovative technologies like gene editing and...
John D.
Nov 28, 20185 min read


The 4 Essential Elements of your vEDS Care Team
When I was first diagnosed, like most people I knew nothing about vascular Ehlers-Danlos. Similarly, many of the doctors who first...
The FightEDS Team
Sep 6, 20184 min read


A vEDS Confession...the 1st time I met another patient
I have a confession to make. I've been diagnosed with vascular Ehlers-Danlos for 6 years, but last month was the first time I met anothe
John D.
Aug 8, 20183 min read


7 Lessons from the vEDS Facebook Community
One of the most challenging aspects of suffering from a rare disease can be the feeling of isolation associated with it. Many patients with

FIGHT vEDS Team
Jun 12, 20185 min read


Fight EDS Version 2.0 Website Now Available!
Version 2.0 of FightEDS provides even more information about vascular Ehlers-Danlos syndrome for patients and their familes
The FightEDS Team
May 25, 20182 min read


The University of Washington and FightEDS ask patients to set the research agenda
As many of you are aware, FightEDS has been working closely with the University of Washington to further research in vascular Ehlers-Danlos

FIGHT vEDS Team
Jan 31, 20182 min read


Congress Attempts to Alter the Orphan Drug Tax Credit
On November 2nd, 2017 the House Ways and Means Committee released a draft of the Tax Cuts and Jobs Act. The proposal has created a stir...

FIGHT vEDS Team
Nov 13, 20173 min read


5 Tips from Benjamin Franklin for vascular EDS
Advice from Benjamin Franklin - how to use prevention and these five tips to better manage vEDS and improve longevity.

FIGHT vEDS Team
Aug 28, 20174 min read


Acer Therapeutics Obtains Exclusive License to Celiprolol Study Data
Acer Therapeutics Inc., a pharmaceutical company based in Cambridge, MA recently signed an agreement with the Greater Paris University...

FIGHT vEDS Team
Dec 14, 20161 min read
bottom of page
